The September 2016 Newsletter includes information about:
- Including patient preferences in clinical trials through Discrete Choice Experiments
- Genomic Cancer Clinical Trials Initiative September 2016 Workshop
- Design, Implementation and Reporting Strategies to Reduce the Instance and Impact of Missing Patient-Reported Outcome (PRO) Data
- Joint ANZBCTG/COSA Annual Scientific Meeting
- Are we Producing Quality Cost-Utility Analyses in Breast Cancer?
- ANZMTG Update
- What has CREST been up to?